Mixed outcomes following a third SARS-CoV-2 vaccine dose in previously unresponsive people with HIV

Affiliations

• ¹ Department of Infectious and Tropical Diseases, Hôpital Avicenne AP-HP, 125 rue de Stalingrad, 93000, Bobigny, France.
• ² Department of Clinical Microbiology, Hôpital Avicenne AP-HP, 125 rue de Stalingrad, 93000, Bobigny, France.
• ³ Department of Clinical Microbiology, Hôpital Avicenne AP-HP, 125 rue de Stalingrad, 93000, Bobigny, France; Faculté de Médecine, INSERM U1137 IAME, Université Sorbonne Paris Nord and Université Paris Cité, 16 rue Henri Huchard, 75018, Paris, France.
• ⁴ Department of Infectious and Tropical Diseases, Hôpital Avicenne AP-HP, 125 rue de Stalingrad, 93000, Bobigny, France; Faculté de Médecine, INSERM U1137 IAME, Université Sorbonne Paris Nord and Université Paris Cité, 16 rue Henri Huchard, 75018, Paris, France.
• ⁵ Department of Clinical Microbiology, Hôpital Avicenne AP-HP, 125 rue de Stalingrad, 93000, Bobigny, France; Faculté de Médecine, INSERM U1137 IAME, Université Sorbonne Paris Nord and Université Paris Cité, 16 rue Henri Huchard, 75018, Paris, France. Electronic address: heloise.delagreverie@aphp.fr.